Development and Psychometric Testing of HPV Knowledge Scale

June 17, 2024 updated by: Yudisa Diaz Lutfi Sandi, Kaohsiung Medical University

Development and Psychometric Testing of a Questionnaire to Assess HPV Knowledge in Indonesia

The aim of this study is to develop and conduct psychometric testing of a new scale, the Human Papillomavirus Knowledge Scale (HPV-KS), particularly designed to assess HPV knowledge among parents of school-age children in Indonesia.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

research process after obtaining school principal. because the target population was parents who have daughters in elementary schools.

All participants (parents) were recruited from 5 elementary schools. According to a minimum sample size estimation for a psychometric study, it needs 10 times the total number of items (Boateng, 2018). the total participants, 52 items x 10= 520 participants were required.

The researchers got approval from schools to invite parents to attend the school of event invitations. Each participant came to the school where their child attended. Parents attended the regular meeting on the appointed day. at that time, researchers approached potential participants to explain to them the purpose of this study, participant rights, risks, and benefits. The researcher obtained participants' consent to participate in this research with a serial number.

During the process, researchers keep the participant anonymous. The questionnaires were distributed to the participants and took around 15-20 minutes to complete. All data was recapitulated and stored in Excel format. Data were kept by the researcher to maintain confidentiality. All data analyses were performed using SPSS software from IBM Corp.

Statistical analyses are below:

  1. Descriptive analysis was used to identify population characteristics
  2. Validity testing contains Exploratory and Confirmatory factor analyses were structure and construct.
  3. Reliability testing was done using Cronbach alpha to determine the instrument's reliability.

Study Type

Observational

Enrollment (Actual)

673

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • East Java
      • Ngawi, East Java, Indonesia, 63271
        • Elementary school

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All participants were parents who had children in elementary school. they come from several different educational variations, ethnicities, religions, places of residence, and economic levels. This research involved five elementary schools in rural areas. The population in rural was chosen to provide an overview of the understanding of rural communities regarding the feasibility of this new instrument.

Description

Inclusion Criteria:

  • Participants have a child in elementary school
  • Participants could speak Bahasa Indonesia fluently
  • Participants live with their children in one house
  • Participants are willing to participate in the study

Exclusion Criteria:

  • parents had mental, visual, and hearing impairments or problems diagnosed by doctors
  • their children' age are over 14 years old.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Human papillomavirus knowledge scale
Time Frame: one time collected. participants took 15 minutes to complete all items in form.
it consists of 3 subscales assessed awareness and understanding about human papillomavirus that encompass transmission, related to diseases, prevention, vaccine domestic policy context. it has a binary response format with a true /false response. the items contain favourable and unfavourable statement. A 1-point reflects that the answer is correct and 0-point is incorrect answer. The total scores indicated the knowledge level. The higher score means a better knowledge level
one time collected. participants took 15 minutes to complete all items in form.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Actual)

April 1, 2023

Study Completion (Actual)

May 1, 2023

Study Registration Dates

First Submitted

June 11, 2024

First Submitted That Met QC Criteria

June 17, 2024

First Posted (Estimated)

June 19, 2024

Study Record Updates

Last Update Posted (Estimated)

June 19, 2024

Last Update Submitted That Met QC Criteria

June 17, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 421/061/404.102.28/II/2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parent-Child Relations

Clinical Trials on Psychometric Group

3
Subscribe